← back to search

L. Gibbons

NIHR Clinical Research Network · US
Area of research
Nuclear and High Energy Physics
Research interest
Research interests include Particle physics theoretical and experimental studies, Quantum Chromodynamics and Particle Interactions, High-Energy Particle Collisions Research, and Dark Matter and Cosmic Phenomena.
h-index
119
citations
75,222
works
898
NIH funding
primary concept
Physics
email

Recent publications

A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results
Annals of Oncology 2024cited by 58position: middledoi
Detailed report on the measurement of the positive muon anomalous magnetic moment to 0.20 ppm
Physical review. D/Physical review. D. 2024cited by 52position: middledoi
Detailed report on the measurement of the positive muon anomalous magnetic moment to 0.20 ppm
Physical Review D 2024cited by 39position: contributordoi
Measurement of the Positive Muon Anomalous Magnetic Moment to 0.20 ppm
Physical Review Letters 2023cited by 365position: middledoi
Measurement of the Positive Muon Anomalous Magnetic Moment to 0.20 ppm.
2023cited by 24position: contributordoi
Measurement of the Positive Muon Anomalous Magnetic Moment to 0.46 ppm
Physical Review Letters 2021cited by 1,321position: middledoi
Measurement of the anomalous precession frequency of the muon in the Fermilab Muon<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:mi>g</mml:mi><mml:mo>−</mml:mo><mml:mn>2</mml:mn></mml:math>Experiment
Physical review. D/Physical review. D. 2021cited by 196position: middledoi
Magnetic-field measurement and analysis for the Muon <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mi>g</mml:mi><mml:mo>−</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math> Experiment at Fermilab
Physical review. A/Physical review, A 2021cited by 103position: middledoi
Measurement of the Positive Muon Anomalous Magnetic Moment to 0.46 ppm.
2021cited by 76position: contributordoi
Updated measurements of absolute<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:mrow><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:math>and<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:msup><mml:mi>D</mml:mi><mml:mn>0</mml:mn></mml:msup></mml:math>hadronic branching fractions and<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:mi>σ</m
Physical review. D. Particles, fields, gravitation, and cosmology/Physical review. D, Particles, fields, gravitation, and cosmology 2014cited by 37position: middledoi
Improved measurement of absolute hadronic branching fractions of the<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:msubsup><mml:mi>D</mml:mi><mml:mi>s</mml:mi><mml:mo>+</mml:mo></mml:msubsup></mml:math>meson
Physical review. D. Particles, fields, gravitation, and cosmology/Physical review. D, Particles, fields, gravitation, and cosmology 2013cited by 44position: middledoi
First Measurement of the Form Factors in the Decays<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:msup><mml:mi>D</mml:mi><mml:mn>0</mml:mn></mml:msup><mml:mo>→</mml:mo><mml:msup><mml:mi>ρ</mml:mi><mml:mo mathvariant="bold">−</mml:mo></mml:msup><mml:msup><mml:mi>e</mml:mi><mml:mo mathvariant="bold">+</mml:mo></mml:msup><mml:msub><mml:mi>ν</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math>and<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mm
Physical Review Letters 2013cited by 36position: middledoi
Updated measurement of the strong phase in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:msup><mml:mi>D</mml:mi><mml:mn>0</mml:mn></mml:msup><mml:mo>→</mml:mo><mml:msup><mml:mi>K</mml:mi><mml:mo mathvariant="bold">+</mml:mo></mml:msup><mml:msup><mml:mi>π</mml:mi><mml:mo mathvariant="bold">−</mml:mo></mml:msup></mml:math>decay using quantum correlations in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:msup><mml:mi>e</mml:mi><mml:mo m
Physical review. D. Particles, fields, gravitation, and cosmology/Physical review. D, Particles, fields, gravitation, and cosmology 2012cited by 38position: middledoi
Amplitude analysis of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:msup><mml:mi>D</mml:mi><mml:mn>0</mml:mn></mml:msup><mml:mo>→</mml:mo><mml:msup><mml:mi>K</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:msup><mml:mi>K</mml:mi><mml:mo>−</mml:mo></mml:msup><mml:msup><mml:mi>π</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:msup><mml:mi>π</mml:mi><mml:mo>−</mml:mo></mml:msup></mml:math>
Physical review. D. Particles, fields, gravitation, and cosmology/Physical review. D, Particles, fields, gravitation, and cosmology 2012cited by 31position: middledoi

Grants

Instructional Equipment For the Study of Biobehavior Interactions
NSF7914736$2,5251979–1982PIRePORTER

Frequent collaborators

Cristina Hernándo · Hospital Clínico Universitario de Valencia1 papers (2024–2024)Manuel Ruíz‐Borrego · Royal College of Surgeons in Ireland1 papers (2024–2024)Anne Armstrong · University of Manchester1 papers (2024–2024)Maila Dayane Capuchinho de Oliveira · Southwest Bahia State University1 papers (2024–2024)Teresa Klinowska · AstraZeneca (United Kingdom)1 papers (2024–2024)Nicholas C. Turner · Queensland University of Technology1 papers (2024–2024)J. García-Corbacho · Hospital Clínic de Barcelona1 papers (2024–2024)Christos Vaklavas · University of Utah1 papers (2024–2024)Christopher J. Morrow · AstraZeneca (United Kingdom)1 papers (2024–2024)Justin P.O. Lindemann · AstraZeneca (Netherlands)1 papers (2024–2024)Jason Incorvati · Case Comprehensive Cancer Center1 papers (2024–2024)D. Cauz · Universitat de Barcelona1 papers (2021–2021)Eva Ciruelos · Breast Cancer Research Foundation1 papers (2024–2024)Chris Twelves · University of Leeds1 papers (2024–2024)Richard D. Baird · Cancer Research UK1 papers (2024–2024)Tim Brier · AstraZeneca (United Kingdom)1 papers (2024–2024)Mehul Patel · Sarasota Memorial Hospital1 papers (2024–2024)Manuel Ruíz Borrego · Universidad de Sevilla1 papers (2024–2024)D. W. Hertzog · University of Washington1 papers (2021–2021)S. Lee · University of Washington1 papers (2021–2021)